Skip to content
healthcare.dev

Erythromycin Ethylsuccinate

NDC 52536-134, Erythromycin Ethylsuccinate, granule, for suspension, from Wilshire Pharmaceuticals Inc..

Product NDC
52536-134
Status
Listed
Labeler
Wilshire Pharmaceuticals Inc.
Dosage form
GRANULE, FOR SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA050207
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/52536-134 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERYTHROMYCIN ETHYLSUCCINATE200 mg/5mL

Pharmacologic classes

Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]

Package NDCNDC-11Package
52536-134-1352536013413100 mL in 1 BOTTLE (52536-134-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/f4a3fffd-ce02-450f-bbcc-d425374e3e32
  • NADAC price for package 52536013413

    GET /v1/drugs/nadac/52536013413

Use it

Look up 52536-134 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/52536-134 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 52536-134. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.